Clinical Trial Update: FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.

View source ↗

Summary

A clinical trial from Maimónides Biomedical Research Institute of Córdoba is examining the relationship between fibroblast growth factor 23 (FGF23) and cardiova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Snippet

Sponsor: Maimónides Biomedical Research Institute of Córdoba | Conditions: Fibroblast Growth Factor 23, Anemia | Status: RECRUITING